Tramadol Hydrochloride
Product Images NDC 68071-2329

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-2329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2329 6)

Label for Tramadol Hydrochloride 300 mg extended-release tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 60 tablets and includes warnings about habit forming and federal law restrictions on drug transfer. The label also notes storage temperature, prescription-only status, and manufacturer details for Lupin Limited, with a product number P2224060.*

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of Tramadol Hydrochloride showing its molecular configuration including rings, hydroxyl group, methoxy group, amine side chain, and the hydrochloride component as indicated by .HCl.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph comparing Tramadol concentration (ng/mL) over time (hours) for two formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg q.d. and Tramadol Hydrochloride Tablets 50 mg q6h. The graph displays plasma concentration profiles over a 24-hour period for each dosage form, illustrating the pharmacokinetic differences between the extended-release and immediate-release formulations.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line chart depicting the concentration of M1 (ng/mL) over 24 hours comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg taken once daily versus Tramadol Hydrochloride Tablets 50 mg taken every 6 hours. The y-axis represents M1 concentration and the x-axis represents time in hours. Two lines with different markers show the concentration trends over time.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' shows percent of patients achieving various response thresholds. The x-axis indicates response threshold as percent improvement from baseline (0 to 100%), and the y-axis shows percent of patients achieving response (0 to 60%). It compares Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, 400 mg, and placebo groups, each represented by distinct markers and lines.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph depicting Tramadol Hydrochloride Extended-Release Tablets Study 015 on arthritis pain intensity VAS responder analysis. The x-axis represents response threshold as percent improvement from baseline, ranging from 0 to 100. The y-axis shows percent of patients achieving response, from 0 to 60. Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo, showing higher responder percentages for the Tramadol group across thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.